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A deletion mutant of the colicin El-derived plasmid, pDMS6642, exhibited an
approximately fourfold increase in copy number. We subsequently isolated
hydroxylamine-induced mutants of that plasmid that had a further increase in
copy number. Analysis of them suggests that the increased copy number of
pDMS6642 is associated with transcriptional readthrough from a Tn3 transposon
into the region of ColEl containing information that influences plasmid replication. The hydroxylamine mutation in one copy number mutant appeared to
increase the plasmid copy number by stimulating readthrough transcription from
the Tn3 transposon into the ColEl replication control region, whereas the other
hydroxylamine mutation acts by another mechanism.

Plasmid ColEl is stably maintained in Escherichia coli strains as a monomeric molecule with
a copy number of about 15 per chromosome.
Oka et al. (21) have shown that a 420-base-pair
(bp) sequence that includes the ColEl replication origin (the rep region) provides all of the
information essential for autonomous plasmid
replication. It was subsequently shown that a
nucleotide sequence between 400 and 600 bp
upstream from the replication origin codes for an
RNA that influences plasmid copy number (4-6,
18, 25) and incompatibility (RNAI) and also
contains a promoter of an RNA primer of ColEl
replication (14).
We previously constructed a deletion mutant
called pDMS6642 from a ColEl-derived plasmid. It contains about 860 bp of ColEl DNA
fused to the portion of the Tn3 transposon that
contains the P-lactamase gene and a part of the
tnpR gene (8, 12; Fig. 1). pDMS6642 has a copy
number of about 57 per cell genome. Two hydroxylamine-induced copy number mutant derivatives of pDMS6642 were isolated based on
their ability to confer high ampicillin resistance
on their hosts. One of those mutants also exhibited a higher production of j-lactamase per
plasmid. Further mapping of the mutations and
the introduction of insertions that blocked
readthrough transcription from the Tn3 transposon into the ColEl replication control region led
to the conclusion that readthrough transcription
from the Tn3 transposon is the principal cause of
the high copy number of both pDMS6642 and
the mutant that exhibited the increased production of P-lactamase per plasmid.

MATERILS AND METHODS
Bacteria, plasmids, and plasmid derivations. The
strains of E. coli which were used were P678-54 (thr
845

leu thi rpsT Sm') (5, 6) and Om84 [tyr(Am) trp(Am) thy
his ilv supD] (5, 6). Each strain contained appropriate
plasmids which were introduced by standard DNA
transformation methods (see below). The plasmids
used are shown in Table 1, and their construction is
shown in Fig. 1. pDMS630 is ColEl containing a Tn3
transposon which confers ampicillin resistance (5).
pDMS66 (13) is a mutant of pDMS630 in which the
end of the Tn3 transposon associated with the ,3lactamase gene is fused to the ColEl DNA 684 bp
upstream from the ColEl replication origin (20) and
129 bp upstream from the promoter that initiates
transcription of the RNA primer of ColEl replication
(10). pDMS6642 was formed by constructing a plasmid
that contains only two HaeII-generated DNA fragments observed in pDMS66 (Fig. 1). One contains a
part of the ColEl DNA that extends from 185 to 684 bp
upstream from the replication origin and is fused to a
(approximately 1,200 bp) portion of the Tn3 transposon that includes the P-lactamase gene and a portion of
the tnpR gene (8, 12, 13, 20). The other fragment is the
360-bp HaeII fragment E that contains the ColEl
replication origin (12, 13, 20). These two fragments
were ligated to form pDMS6642. They can only be
joined in one way to generate a functional plasmid
(11). The location of the BamHI- and PstI-sensitive
sites in the Tn3 portion of the plasmid has previously
been identified (8, 10, 13, 24). pDMS1005 (Fig. 1) is a
chimera formed by ligating the BamHI-cleaved
pDMS6642 and pHSG1, which is a temperature-sensitive DNA replication mutant of pSC101 (5, 7) that was
previously used in constructing chimeras with ColEl
plasmid derivatives (5). Such chimeras exhibit temperature-resistant replication so long as the ColEl
component can replicate normally (3, 5, 6). Such
chimeras have been shown to exhibit the copy number
of the ColEl plasmid component. No complementation occurs between pHSG1 and ColEl plasmid derivatives.
pDMS1005 DNA was treated with hydroxylamine
(7), and P678-54 transformants exhibiting high ampicillin resistance (4 mg/ml) were selected. Plasmids from
two such transformants, pLS53 and pLS102, were
studied. The pDMS6642 component of pLS53 and
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FIG. 1. A diagrammatic representation of the plasmids involved in the formation of pDMS6642, pDMS1005,
and the hydroxylamine-induced mutants derived from them. pDMS630 is ColEl containing a Tn3 insertion in
HaeII fragment C of ColEl. Plasmid sizes are given in daltons. Endonuclease-sensitive sites shown are BamHI
(Y), HaeII (a), and PstI ( I ). A through F are HaeII fragments of ColEl DNA. The HaeII fragments of Tn3 are
not identified. rep is the smallest identifiable region containing sufficient information to permit autonomous
ColEl DNA replication. RNAI is the region coding for an RNA transcript that affects ColEl copy number. RNA
primer (-p) is the site of initiation and direction of transcription of an RNA primer of ColEl DNA replication. ori
(V) is the site at which the first deoxyribonucleotide of DNA replication is attached to the RNA primer. The
direction of replication is noted (--+). OP - locates the promoter and direction of transcription of the ,B-lactamase
gene ( KXX) contained in one end of the Tn3 transposon ( E X). Part of the tnpR gene (AtnpR) is located in
the Tn3 DNA in pDMS6642. 1
is the tetracycline resistance region in pHSGI, a temperature-sensitive
replication mutant of pSC101 containing the gene that confers tetracycline resistance on host cells. pLS53 and
pLS102 are hydroxylamine mutants derived from pDMS1005 that confer a high ampicillin resistance phenotype
on their hosts. pLS57 and pLS103 are pDMS6642 mutants isolated from pLS53 and pLS102, respectively.
Diagrams are not drawn to scale.

pLS102 was recovered by cleaving the DNAs with PstI-sensitive site (see Fig. 3). It will only confer a
BamHI, ligating the DNAs, and selecting ampicillin- tetracycline resistance phenotype on its host if a
resistant transformants that contained plasmids that promoter is inserted in the appropriate orientation at
were physically indistinguishable in size and restric- the PstI-sensitive site. The expression of tetracycline
tion endonuclease digestion patterns from pDMS6642 resistance after such a ligation leads to the expression
(Fig. 1). As these plasmids exhibited higher copy of a tetracycline resistance phenotype that is propornumbers and conferred higher levels of ampicillin tional to the promoter activity (2). The plasmid pST29
resistance on their hosts than did pDMS6642, they was a generous gift of J. Tomizawa and T. Som. It is a
were designated pLS57 and pLS103.
derivative of RSF1030 and contains a 1,870-bp PstI
Plasmid pGA46 was a generous gift of G. An (2; Fig. fiagment carrying a chloramphenicol resistance gene
3). It contains a promoterless tetracycline resistance that derives from phage PlCm (1).
gene that can be expressed if linked to a promoter by a
Media. LS broth and LS agar are standard nutrient
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TABLE 1. Plasmids used
Plasmid

phenotypea

Endonuclease-sensitive sites (no.)"

(10P

daltons)

Origin of plasmid

7.0
BamHI (1) EcoRI (1) HaeII (10) PstI (4)
pDMS630
Ap
(8, 13, 24)
3.4
BamHI (1) HaeII (7) PstI (1)
pDMS66
Ap
(13)
1.7
BamHI (1) HaeII (2) PstI (1)
pDMS6642
Ap
(12; Fig. 1)
7.8
BamHI (2)
pDMS1005
Ap
Fig. 1
6.1
BamHI (1) EcoRI (1)
pHSG1
Tc, Ts rep.
(5-7)
Tomizawac (Fig. 3)
Cm
PstI (2)
pST29
2.9
Potential Tc PstI (1)
pGA46
(2; Fig. 3)
7.8
Same as pDMS1005
pLS53
Ap
Fig. 1
7.8
pLS102
Same as pDMS1005
Ap
Fig. 1
1.7
Same as pDMS6642
pLS57
Ap
Fig. 1
1.7
Same as pDMS6642
pLS103
Ap
Fig. 1
Cm
PstI (2)
2.9
pLS75
Fig. 3
Cm
2.9
pLS77
PstI (2)
Fig. 3
Cm
PstI (2)
2.9
pLS109
Fig. 3
4.6
Tc
PstI (2)
pLS83
Fig. 3
4.6
Tc
PstI (2)
pLS84
Fig. 3
a Drug resistance phenotype conferred by plasmids are ampicillin (Ap), chloramphenicol (Cm), tetracycline
(Tc). pHSG1 exhibits temperature-sensitive replication (Ts rep.).
b Endonuclease-sensitive sites used in ligation. The sites shown in pDMS630, pDMS66, and pDMS6642
represent all sites of those types in those plasmids.
C pST29 was obtained from the laboratory of J. Tomizawa. A PstI fragment (1.2 x 106
daltons) (1) was isolated
from the plasmid for insertion into other plasmids.

media which have previously been described (5). M9
minimal medium has previously been described (5, 6).
It was supplemented with 5 ,ug of thymine per ml,
appropriate amino acid supplements (40 ,ug/ml), or
0.4% Casamino Acids (Difco Laboratories). It was
used for radioactive labeling of plasmid DNA. The
concentration of antibiotics in broth or agar was
usually 200 ,ug of ampicillin per ml and 5 jig of
tetracycline per ml. Much higher concentrations of
drugs were used in testing the maximum allowance
concentration (MAC) of drugs. Tetracycline was prepared as needed as a 2-mg/ml solution.
Isolation and purification of plasmid DNA. Plasmid
DNA was released from cells by the cleared lysis
procedure exactly as described previously (5). The
covalently closed circular plasmid DNA was banded in
cesium chloride-ethidium bromide density gradients
and isolated exactly as previously described (5). The
plasmid DNA was dialyzed against an appropriate
buffer. Subsequently, the plasmid DNA was either
directly examined by agarose gel electrophoresis or
first digested with particular endonucleases followed
by gel electrophoresis analysis of the fragments generated. The endonuclease digestions were always used
to determine whether plasmids formed by ligating
specific DNA fragments together had the appropriate
structure. Those data are not included in the presentation, although they are referred to in the text.
Transformation of bacteria with DNA. The method
used for transformation was exactly as previously
described (5, 16). The phenotype of the transformants
selected was drug resistance or colicin immunity (5, 6).
Measurement of the MAC. Overnight cultures were
diluted so that they contained between 2 x 103 and 1 x
10' bacteria per ml. A 0.1-ml amount of culture was
plated on LS agar and on LS agar with various
amounts of active ampicillin (200 jig to 22 mg/ml).
Ampicillin trihydrate was a gift from Bristol Labora-

tories. It contains 849 ,ug of ampicillin per mg. The
lowest drug concentration that inhibited the growth of
greater than 99% of bacteria was determined. It was
almost always noted that a dramatic decline in viable
counts of plasmid-containing cells was observed over
a 0.5- to 1.0-mg/ml difference in active ampicillin
concentration. That drug concentration above which
an abrupt decline in viable counts occurred was called
the MAC.
The measurement of tetracycline resistance was
conducted essentially as described above. Tetracycline and tetracycline-containing agar were always
freshly prepared, and the agar was kept in the dark.
The inhibition of bacterial growth with increasing
amounts of tetracycline was unequivocal and reproducible when measured in increments of 5 ,g of
tetracycline per ml.
Measurement of (3-lactamase activity. P-Lactamase
assays were done by a slight modification of the
iodometric method described by Sherratt and Collins
(23). Bacterial cultures were centrifuged at 4,000 rpm
for 10 min. One milliliter of the supernatant was added
to duplicate tubes containing 2.5 ml of substrate solution (2.4 mg of ampicillin in 0.1 M phosphate buffer
[pH 7.0]) at 30°C and shaken gently in a 30°C water
bath for 15 min. A 5-ml amount of 0.016N I-0.06 M
KI in 2 M sodium acetate buffer (pH 4.2) was then
added to each substrate tube. A 1.0-ml amount of the
supernatant being tested was added to a control tube.
The tubes containing the iodine solution were incubated a further 10 min to allow the iodine to react with the
ampicilloic acid generated by the reaction of the ,Blactamase with ampicillin. Both the sample and control
were centrifuged at 12,000 rpm for 10 min. The absorbance of the supernatant was read at 499 nm in a glass
cuvette with a 1-cm light path. The difference in
absorbance between the sample and control tubes was
corrected to ,B-lactamase units per milliliter (22, 23) by
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multiplying the total volume of liquid (in milliliters) in
the total mixture and correcting to t ml of sample and 1
h of incubation.
Viable counts on agar plates containing 200 ,ug of
ampicillin per ml were made of all cultures tested, and
the ,-lactamase units per milliliter were converted to
,B-lactamase units per 108 Apr cells in the culture.
When a plasmid copy number was determined, the Plactamase units per 10' plasmids was determined by
dividing the ,-lactamase units per 108 cells by the
plasmid copy number.
Enzymatic digeston, ligation, and agarose gel electrophoresis of DNA. Enzymatic digestion, ligation, and
agarose gel electrophoresis were performed as previously described (6).
Determination of plasmid copy number. Plasmid
copy number was calculated from the [3H]thymidinelabeled DNA in the covalently closed circular peak in
a cesium chloride-propidium diiodide density gradient
exactly as previously described (6). A minimum of
three independent determinations was made for all
plasmids. The plasmid copy number determined in this
way rarely varied by more than ±lOo. In all instances, 100%6 of cells in cultures contained plasmids
during the labeling period. It should be noted that
plasmid pDMS6642 does not exhibit "relaxation" because all regions of ColEl that are essential for relaxation are deleted (10). The cesium chloride-propidium
diiodide method is therefore quite accurate for determining copy numbers since relaxed circles are not
usually produced. This was confirmed by mixing 3Hlabeled covalently closed circular DNA with lysates
and demonstrating an absence of nicking. Also, to
insure that mutants didn't produce significant amounts
of unusual relaxed plasmid DNA, we analyzed total
lysates by agarose gel electrophoresis. No unusual
plasmid ban4s were identified, thus ruling out that
possible source of underestimating plasmid copy number.
Measurements of plasmid stability. A plasmid-containing colony was picked from an appropriate selective agar and suspended in LS broth, and the cultures
were incubated at either 30 or 42°C. These cultures
were diluted about 1/1,000 every 12 h and grown for up
to 40 generations. The bacterial viable counts of each
culture were determined by plating the cultures on
both LS agar and LS agar containing ampicillin and
incubating them at 30°C. If a constant difference in
plating efficiency was noted on agar with and without
ampicillin, 100 colonies were picked from the LS agar
and tested by a streak test, as previously described (5,
6), to determine the numbers of ampicillin-sensitive
colonies present.
Determination of DNA nudeotide sequence. The
method of Maxam and Gilbert (17) was used for
determining DNA nucleotide sequence.

RESULTS
Isolation and characterization of hydroxylamine-induced plasmid mutants showing increased copy number. The chimeric plasmid
pDMS1005 (Table 1- Fig. 1; see above) was
originally isolated to create a vehicle for identifying mutations which affect the replication of
ColEl. The chimera was produced by ligating
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plasmid pHSG1 (5), which exhibits temperaturesensitive replication, to a ColEl deletion mutant
pDMS6642 (see above) via their BamHI-sensitive sites (Fig. 1). pDMS1005 replication is temperature resistant, indicating that it replicates
via the ColEl replication process (see above; 3,
5, 6). Insertion of DNA into the BamHI-sensitive site of pHSG1 inhibits the expression of the
plasmid-conferred tetracycline resistance phenotype (5), whereas insertion of DNA into the
BamHI-sensitive site in the Tn3 transposon nucleotide sequence of pDMS6642 did not inhibit
,-lactamase expression. pDMS1005, therefore,
confers an ampicillin resistance and tetracycline
sensitivity phenotype on its host. It has previously been shown that when the constitutively
expressed P-lactamase gene is carried on a plasmid, the level of ampicillin resistance manifested
by a host cell is proportional to the plasmid copy
number (9, 19). This was reconfirmed for derivatives of pDMS630, a ColEl derivative used in
these experiments (Table 1, Fig. 1) that were
ligated to pHSG1 (5, 6). Since cells carrying
pDMS1005 were maximally resistant to 1.5 mg
of ampicillin per ml, it was assumed that mutants
which confer a significantly higher level of ampicillin resistance on their hosts would probably
exhibit an increased plasmid copy number. Other causes of increased P-lactamase activity in a
cell must, however, be considered.
pDMS1005 was mutagenized in vitro with
hydroxylamine, as described previously (7, 12),
and that DNA was used to transform E. coli
P678-54. Transformants were selected which
were resistant to at least 4 mg of ampicillin per
ml. The MAC of cells, the MAC per plasmid,
and the P-lactamase production per plasmid of
two independently isolated highly ampicillinresistant mutants, pLS53 and pLS102, are
shown in Table 2. Although pLS53 exhibited a
small but consistent increase in copy number
compared with pDMS1005, pLS102 exhibited an
almost fourfold increase in copy number (Table
2). In the case of pLS102, the increased plasmid
copy number and both increased MACs and 1Blactamase production per cell were consistent
with the interpretation that the increased copy
number is responsible for the increased drug
resistance. In the case of pLS53, the increased
copy number cannot be the sole cause of increased drug resistance.
The localization of the mutation to the
pDMS6642 component in each mutant chimera
was undertaken. The pDMS6642 components of
pLS53 and pLS102 were isolated from the respective chimeras, as described in the legend to
Fig. 1 and above. These plasmids, which were
identical to pDMS6642 in size and endonuclease
cleavage pattern (data not shown), conferred
high levels of ampicillin resistance on their host.
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TABLE 2. Measurements of copy number, ampicillin resistance, and p-lactamase activity
MAC ofMA/-acmse
Stabilitya
ampicillin
Copy no.
Plasmid
plas/id
1p-Lactamase/
42i C
WC

~~~~~~(mg/mi)

300C
420C

lsis

pamd

0.19
0.74
0.24
0.05
0.12
0.06

± 0.04
S
S
pDMS1005
± 0.08
U
S
pLS53
± 0.03
U
S
pLS102
± 0.01
S
S
pDMS6642
± 0.02
U
U
pLS57
± 0.02
U
U
pLS103
0.21 ± 0.02
0.10 ± 0.01
S
S
pDMS630
a S, Stable; U, unstable.
b MAC
per plasmid is the MAC divided by the plasmid copy number.
c ,3-Lactamase per 10' plasmids is the 1-lactamase level per 108 cells in the culture divided by the plasmid copy
number. Each ,B-lactamase assay was performed a minimum of four times.

The pDMS6642-type plasmids isolated from
pLS53 and pLS102 were named pLS57 and
pLS103, respectively (Fig. 1 and Table 2).
The copy number (Table 2) of pDMS6642 was
significantly greater than that of pDMS630, and
both pLS57 and pLS103 had copy numbers
significantly greater than that of pDMS6642.
The MAC per plasmid and ,-lactamase per
plasmid were very similar for pDMS6642 and
pLS103 as they were for pDMS1005 and
pLS102, from which they were derived. The
MAC per plasmid and 3-lactamase production
per plasmid were, however, significantly higher
for pLS57 than for pDMS6642. These findings
are consistent with the interpretation that the
mutation in pLS57 may directly cause an increased P-lactamase production, which secondarily causes the observed increase in plasmid
copy number. They are also consistent with the
interpretation that the mutation in pLS103 affects the control of the plasmid copy number
without altering the 3-lactamase production of
the pDMS6642 plasmid. Since mutations in
pLS57 and pLS103 induce changes in copy
number and ,B-lactamase activity similar to those
exhibited by pLS53 and pLS102, it is reasonable
to assume that the mutation affecting each chimera resides in its pDMS6642 component.
While making these measurements, we determined the stability of all of the plasmids at 30
and 42°C (see above), since if this is not done, an
undetected large plasmid loss during growth
could affect the interpretation of measurements.
The results in Fig. 2 show that both pLS53 and
pLS102 were stable, whereas pLS57 and
pLS103 exhibited a small but detectable instability at 30°C. When cells were grown without
ampicillin for 40 generations, a maximum of 5%
exhibited a loss of plasmids. All of the mutants
were unstable at 42°C (Fig. 2). The plasmid
instability is, therefore, not responsible for the
increased MAC per plasmid of P-lactamase per
plasmid ratio exhibited by pLS53 and pLS57.

0.15
0.80
0.16
0.04
0.19
0.04

1.5
12.0
6.0
2.0
15.0
6.0
1.5

10 ± 1.4
15 ± 1.4
38 ± 4.0
57 ± 2.1
84 ± 3.6
140 ± 7.6
15 ± 1.8

0.02
0.08
0.02
0.002
0.01
0.002

±
±
±
±
±
±

Localization of the mutations affecting pLS57
and pLS103. If an appropriate BamHI-PstI-generated fragment (Table 3) is derived from either
pLS57 or pLS103 and ligated to an appropriate
DNA fragment derived from pDMS6642, the
hybrid plasmid which is formed should express
the mutant plasmid phenotype. pDMS6642,
pLS57, and pLS103 DNAs were each cleaved
with both BamHI and PstI. The fragments (A
and B; Table 3) from each digest were carefully
purified twice by gel electrophoresis. It was
essential to reduce cross-contamination of fragments and to eliminate undigested DNA which
could obscure the results. Each fragment from a
mutant was then ligated to the other fragment
from pDMS6642, and the newly formed hybrid
A
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B
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R.-z- 1:1
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I
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4,)
.

t
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IkI
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C-)

0.1

I
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I
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I
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0
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0
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20 40

generations

FIG. 2. Plasmid stability in cells grown in LS broth
at 30°C (-) or at 42°C (- - - -). (A) pDMS1005 (a),
pDMS6642 (X); (B) pLS53 (0), pLS57 (X); (C) pLS102
(0), pLS103 (X).
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TABLE 3. Results of transformation by plasmids reconstituted from fragments derived from mutants and
pDMS6642
Transformantsb
Source of fragments'
MAC of transformants (mg of
ampicillin per ml)'
4 mg/ml
pDMS6642
200 F.g/ml
Mutant
B
405
2
2
pLS57A
155
A
299
15
pLS57B
2
0
NT
pLS57A
2
10
NT
pLS57B
0
A
0
0
B
0
B
158
5
138
pLS103A
1%
0
2
A
pLS103B
1
0
NT
pLS103A
0
0
pLS103B
0
0
A
0
B
0
a BamHI-PstI digests of the pDMS6642, pLS57, and pLS103 plasmids produce an A and B fragment. These
and
are the portions of the Tn3 transposon not
were independently purified, mixed, and ligated. E
is the ColEl DNA. V is the replication
containing and containing, respectively, the P-lactamase gene.
origin. OP -- is the site of the promoter of the P-lactamase gene and its direction of transcription. -, None.
b The number of transformants in 0.01 ml of transformation mixture plated on L agar containing either 200 ,ug
or 4 mg of ampicillin per ml. The amount of A and B DNA used in controls for ligation and transformation was
identical to that used in the experimental samples.
c The MAC of transformants of each type was taken from the 4-mg/ml plate when possible. NT, Not
tested.

plasmids were introduced into P678-54 by transformation. The ability of the transformants to
grow on 4 mg of ampicillin per ml was initially
taken to indicate that the plasmids had acquired
the mutant phenotype. The plasmid copy number of the transformants was also measured, as
was the MAC of the cells after introduction of
the plasmids into Om84. The results (Table 3)
show that when pLS57 fragment B was ligated to
pDMS6642 fragment A, the new plasmid exhibited the information which led to increased plasmid-mediated 3-lactamase production which
was identical to that exhibited by pLS57. When
the pLS103A fragment was ligated to pDMS6642
fragment B, a new plasmid was also formed that
led to increased plasmid-mediated P-lactamase
production identical to that exhibited by
pLS103. The newly formed plasmids had copy
numbers which were the same as pLS57 and
pLS103 (data not shown).
The fragment 103A contains the nucleotide
sequence for the ColEl RNA1 product in which
mutations have been shown to cause an increased-copy-number phenotype (4, 18). The
negative results of the reverse ligation and the
negligible background transformation of individual fragments eliminated the possibility that the

transformants were produced by reconstituted
or contaminating original mutant DNA (Table
3).
Fragment B from pLS57 (illustration, Table 3)
contained only Tn3 DNA. The BamHI- and
PstI-sensitive sites, which are not in the ColEl
DNA of pDMS6642, have been sequenced in the
Tn3 transposon (8, 24). Included in the Tn3
sequence are the ,B-lactamase promoter region
and a portion of the tnpR gene which does not
include its promoter (Fig. 1; 8, 24). The HaeIIsensitive site in Tn3 closest to the P-lactamase
gene splits the tnpR gene (8). Since the MAC of
cells carrying pLS57 is increased, it was thought
that pLS57 contained an up-promoter mutation
in the previously identified P-lactamase promoter. A Sau3A-1 fragment was identified, which
contains the 1-lactamase promoter region of
the gene in pDMS6642 (24; Dyann Worth, personal communication). The region surrounding
the P-lactamase promoter of pLS57 and
pDMS6642 was sequenced by the Maxam-Gilbert method (17). The sequence, which extended
for 50 nucleotides above and 100 nucleotides
below the Pribnow box located at the beginning
of the j-lactamase sequence (24; data not
shown), was identical to that reported by Sutcliff
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(24). The mutation in pLS57 is, therefore, not in
the immediate region identified with the promoter sequence of the 1-lactamase gene, but toward
or in the tnpR gene sequence. There are about
650 nucleotides between the P-lactamase promoter and the point at which the tnpR gene has
been cut (8; Fig. 1).
Role of transcription from the Tn sequence of
pDMS6642 on plasmid copy number. The effect
of the mutation located in the pLS57 Bam-Pst
fragment B of both increasing P-lactamase production and plasmid copy number suggested the
hypothesis that the high copy number of
pDMS6642 and its mutants may be influenced by
readthrough transcription from the TnO portion
of the plasmid into the ColEl DNA adjacent to
it. The ColEl DNA which is adjacent to the TnO
transposon contains the replication control information of the plasmid which is expressed at
the transcriptional level (25). Endonuclease fragment mapping of pDMS66 and pDMS6642 (data
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not shown) indicates that both the j-lactamase
gene and the part of the tnpR gene that is present
are oriented so that the normal transcription
direction of those Tn3 sequences is towards the
ColEl replication control region (8). The readthrough transcription hypothesis was tested by
examining the effect on plasmid copy number of
introducing insertions into the PstI site of
pDMS6642 and its mutants.
A 1,900-bp PstI-generated fragment from
pST29 (which codes for chloramphenicol resistance) was inserted into the PstI site of
pDMS6642, pLS57, and pLS103 in both orientations (Table 1 and Fig. 3). The sequence of the
inserted fragment contains at least one transcription termination site associated with the chloramphenicol resistance gene, as well as other
potential genetic information (1). The copy numbers of plasmids pLS77-1 and 2 (containing the
insertion into pMS6642 in each orientation) and
pLS75-1 and 2 (containing the insertion into
Oft

a
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pLS5T

pST 29

p LS 103

PS,

~~~~~St

p

Pst

Pst
FIG. 3. Diagrammatic representation of the formation of insertions into the PstI-sensitive site of pDMS6642,
pLS57, and PLS103. Insertion derivatives of pDMS6642 are pLS77 and pLS84. Insertion derivatives of pLS57
are pLS75 and pLS83. pLS109 is an insertion derivative of pLS103. The two possible orientations (1 and 2) of the
PstI fragment (-) derived from pST29 are not distinguished in the diagram. That fragment contains information
conferring chloramphenicol resistance (Cm). * P is the location of the ,B-lactamase promoter and v P is the
location of the promoter of the RNA primer of ColEl DNA replication. -- indicates the direction of
is part of the
transcription. X Ori is the origin of DNA replication. E is part of the Tn3 transposon.
is part
pGA46 conferring tetracycline (Tc) resistance when fused with a promoter-containing sequence.
of the end of the P-lactamase gene with one end defined by the PstI-sensitive site.
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pLS57 in each orientation) were reduced to
about 20 copies per chromosome. The copy
numbers of pLS109-1 and -2 (containing the
insertion into pLS103 in each orientation) exhibited an absolute reduction in copy number similar to that shown by pLS77-1 and -2, but the final
base-line copy number was much higher than
that of pLS77-1 and -2 or pLS75-1 and -2 (Table
4). The effects on copy number appeared to be
independent of the direction of insertion (Table
4). The insertion had the predicted effect of
reducing the copy number of all three plasmids,
supporting the hypothesis that the high copy
number of pDMS6642 depends on a continuity
between the region of the Tn3 transposon upstream from the PstI site and the ColEl genetic
information involved with the plasmid's replication control. The fact that the effect was to
reduce the copy number of pLS57 and
pDMS6642 to the same base line while reducing
the copy number of pLS103 to a higher base line
cannot be considered insignificant. The mutation in pLS57 maps upstream, in terms of transcription (8), from the PstI site, and affects 3lactamase synthesis, whereas the mutation in
pLS103 maps downstream from the PstI site and
doesn't effect P-lactamase synthesis. The facts
that in the inserted sequence (i) there is at least
one nucleotide sequence identifiable as a transcription termination site, (ii) numerous translational termination sites exist that possibly could
affect transcription, and (iii) other genetic information is probably coded for provide a variety of

TABLE 4. Effect on copy number of inserting a
DNA fragment into the PstI-sensitive site of
pDMS6642 and its derivatives
Parental plasmida

Plasmid + insertion'

pLS77-1c
pLS77-2
pLS75-1c
pLS7S-2
pLS109-1c
pLS109-2
pLS84d

Copy no.

23
21
24
pLS57 (84)
21
99
pLS103 (140)
122
22
pDMS6642
20
pLS83d
pLS57
a The parental plasmid into which the insertion was
introduced. The number in parentheses is that plasmid's copy number.
b No. 1 and 2 refer to an arbitrary designation of the
orientation of the inserted fragment (Fig. 3) as determined by endonuclease cleavage of the plasmids and
subsequent electrophoretic analysis of the DNA (data
not shown). The orientations are identical in all plasmids designated 1 and in all designated 2.
c The inserted DNA is a PstI-cleaved 1,900-bp fragment derived from pST29 containing a chloramphenicol resistance gene.
d The inserted DNA is a PstI-cleaved
pAG46.

pDMS6642 (57)

possible explanations of the effect of the insertion on copy number (1).
The effect on plasmid copy number of inserting another large DNA fragment with more than
one site for termination of transcription, pGA46
(4,600 bp), was tested by inserting it into the
PstI-sensitive site of pDMS6642 to form the
plasmid pLS84 and into the PstI-sensitive site of
pLS57 to form the plasmid pLS83 (Fig. 3). One
further advantage of using pGA46 plasmid DNA
in this test is that when cleaved with PstI, a
promoterless nucleotide sequence that can potentially express tetracycline resistance is exposed. The level of tetracycline resistance conferred by attaching a particular promoter to the
pGA46 sequence is reported to be proportional
to the transcriptional activity stimulated by it
(2). Therefore, as a result of inserting pGA46
into these plasmids, two different effects should
be seen if the interpretation of the previous
results is to be supported. First, the insertion
should reduce the copy number of both
pDMS6642 and pLS57 to the same extent as
previously observed with the 1,900-bp fragment.
Second, the promoter(s) that affect pLS57 copy
number and P-lactamase production should
cause a higher level of expression of tetracycline
resistance by pGA46 than the promoter(s) of
pDMS6642.
The result of inserting pGA46 into pDMS6642
and pLS57 was to reduce the copy number of the
chimeras pLS84 and pLS83 to 22 and 20 copies,
respectively (Table 4). Both chimeras expressed
tetracycline resistance. pLS84-containing cells
grew on agar containing 5, but not 10, jig of
tetracycline per ml, whereas pLS83-containing
colonies grew on agar containing 15, but not 20,
,ug per ml. The higher tetracycline resistance
conferred by pLS83 is, therefore, not related to
plasmid copy number. The result suggests that
transcriptional activity is higher in the Tn3 region of pLS57 than in the same region of
pDMS6642. It also shows that the insertion
reduces the copy number of both plasmids to the
same level, which was identical to the level
caused by inserting the PstI fragment carrying
the chloramphenicol resistance gene into the
same site. It should be noted that for the chimeras pLS83 and pLS84 to produce a tetracycline
resistance phenotype, the plasmids necessarily
had to be inserted in one particular orientation
(Fig. 3; 2). If they had been inserted in the
opposite orientation, a chimera that would confer a tetracycline sensitivity-ampicillin resistance phenotype would have been produced because the PstI-sensitive site in pGA46 is at one
end of the terminal part of a P-lactamase gene.
The inverted insertion would have matched the
first part of the P-lactamase gene of pDMS6642
with the last part of the P-lactamase gene, which
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is all of that gene that exists in pGA46 (Fig. 3).
This was not observed in either pLS83 or
pLS84. The result, therefore, further supports a
model of readthrough transcription affecting
copy number and directly supports the interpretation that 3-lactamase production per pLS57
plasmid is increased.
DISCUSSION
The copy number of pDMS6642 was reduced
from 57 to about 20 per chromosome after either
a 1,900- or 4,600-bp fragment was inserted into
the PstI-sensitive site of the Tn3 P-lactamase
gene carried by the plasmid. As has been noted
before (5, 6) and as was illustrated here, the
copy numbers of the ColEl plasmid derivatives
are not simply a reflection of plasmid size. If
they were, very different effects of the two
insertions should have been seen. The cause of
the reduction in plasmid copy number by these
insertions is of interest because the insertions
are at a point between at least one well-characterized constitutively active promoter of P-lactamase and a well-characterized deletion (20)
carried in pDMS6642 that fused the end of the
,-lactamase gene to the ColEl nucleotide sequence about 129 bp upstream of the promoter
for the RNA primer of ColEl DNA replication.
As both insertions have transcription termination signals (1, 2), it seems reasonable to think
that the reduction of the copy number of
pDMS6642 to the same level by both insertions
was due to a block in transcription readthrough
from the Tn3 region and was not due to several
independent but identical effects of transcription
that was initiated within the different insertions.
It should also be considered that if readthrough
transcription affects ColE1 copy number, then a
large insertion of 1900 bp could very well have
an effect simply on the basis that it may reduce
the efficiency of readthrough, without any specific termination site being present. Nonspecific
transcription termination events have often been
observed when RNAs have been studied. One
such example is the RNA transcripts produced
from the RNA primer promoter of DNA replication of ColEl examined in vitro (14, 25). Some of
those transcripts appear to spontaneously terminate at a variety of sites (14, 25). These findings,
therefore, suggest that the increased copy number of pDMS6642 is caused by readthrough
transcription from the Tn3 region of the plasmid
into the ColEl replication control region.
The hydroxylamine-induced mutation in
pLS57 is located in the Tn3 component of
pDMS6642. The mutation causes an increase in
its host's resistance to ampicillin, increased 1lactamase production per plasmid, and in addition, an increased plasmid copy number. It was
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argued that the increased 1-lactamase transcription in pLS57 further increased the transcriptional readthrough into the ColEl replication
control region and thus caused the increase in
copy number (about 30 copies) over that seen in
pDMS6642. This was supported by the observation that the insertion of the 1,900- and 4,600-bp
fragments into the PstI site of the ,B-lactamase
gene reduced the copy number of pLS57 to 20.
The insertions not only blocked the effect of the
mutation in pDMS6642 on the plasmid copy
number, but also blocked the additional effect of
the hydroxylamine mutation on the copy number. The simultaneous reversal of the copy number effect caused by the deletion in pDMS6642
and the hydroxylamine mutation suggested that
the mechanism by which both caused the increased copy number is the same, namely,
readthrough transcription. The higher production of 1-lactamase per plasmid by pLS57 is
most likely caused by a mutation that has generated a new promoter upstream from the normal
P-lactaqiase promoter, which was found to have
an unchanged nucleotide sequence. The effect of
an increased promoter activity influencing 1lactamase production in pLS57 was further substantiated by demonstrating an increased
expression of a tetracycline resistance gene that
relies on a promoter of the 1-lactamase gene for
expression.
The hydroxylamine-induced mutation in
pLS103 increased the copy number of
pDMS6642 without altering the production of ,Blactamase per plasmid. The mutation is located
in the DNA A fragment shown in the illustration
in Table 3. That DNA fragment contains the end
of the f3-lactamase gene, the replication control
region of ColEl, including the replication origin,
and about 300 to 350 bases (8) that reside between the HaeII-sensitive site that marks a
ColE1-Tn3 junction (Fig. 1, pLS57 and pLS103)
and the BamHI site in the Tn3 DNA. Since the
-mutation did not alter the 1-lactamase production of pLS103, it is assumed that it does not
alter the plasmid copy number by significantly
altering transcription passing through the 1lactamase gene. Mutations in the RNA1 gene of
ColEl, which are in the ColEl replication region, are known to increase the plasmid copy
number (4, 18, 25). If the increased copy number
of pDMS6642 is caused both by readthrough
transcription from a promoter in Tn3 in the
direction of ,B-lactamase transcription and by a
mutation in the DNA A fragment that does not
rely on such readthrough transcription, then it
was reasoned that insertions placed at the PstIsensitive site in pLS103 could dissect the two
processes; causing the increased copy number
of that plasmid. The insertion should lower the
copy number of the pLS103 plasmid by about 35
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copies per chromosome, the amount attributed
to readthrough transcription from Tn3. If the
effect on copy number is unaffected by the
mutation in the DNA A fragment by such an
insertion, the new plasmid (pLS109) will have a
higher base-line copy number than pDMS6642
carrying the same insertions (e.g., pLS77). The
results in Table 4 show that the base-line copy
number of those plasmids (pLS109) was higher
(between 99 and 122) than for pDMS6642, and
the average drop in copy number was about 30.
The result is taken to further support the interpretation that readthrough transcription in
pDMS6642 and its derivatives has a positive
effect on pDMS6642 replication.
The striking consistency of the results obtained from quite different kinds of measurements of the three plasmids, pDMS6642, pLS57,
and pLS103 and their derivatives is taken to
strongly support the model of readthrough transcription affecting the copy number in
pDMS6642.
An increased transcriptional readthrough
from the Tn3 DNA of pDMS6642 or pLS57
could cause an increased plasmid copy number
by affecting the transcription of either the RNA
primer of DNA replication or of the RNAI gene
product. These observations suggest that transcriptional control of ColEl replication in vivo
can be profitably examined by using pDMS6642
and DNA fragments that contain specific modulatable promoters.
This study also points up some problems and
potential advantages of studying the control of
replication of a plasmid from which, as frequently occurs in engineered plasmids, much of the
genetic information has been removed that otherwise buffers the control system from unusual

transcriptional activity.
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